Genome editing of a low-penetrance albinism-associated variant in TYR in patient-derived pluripotent stem cells
Polly J. DowntoniD, Nicola BatesiD, Woods Jon SiD, Antony D. AdamsoniD, Panagiotis I. SergouniotisiD
Abstract
TYR encodes tyrosinase, the enzyme catalysing the initial steps of melanin biosynthesis in melanocytes and retinal pigment epithelia (RPE). TYR c.1205G>A (p.Arg402Gln) is a common genetic variant associated with several pigmentation traits. Notably, when this variant is encountered in specific haplotypic backgrounds in the homozygous state, it predisposes to albinism. We generated an induced pluripotent stem cell (iPSC) line from an affected individual carrying such a homozygous genotype (UMANi255-A), and then used CRISPR-Cas9 to correct the TYR c.1205G>A variant (UMANi255-A-1). The resulting iPSC lines demonstrate capacity for multi-lineage differentiation, providing a useful in vitro model for studying pigmentation biology.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.50
- Field percentile
- top 36%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The contribution of common regulatory and protein-coding TYR variants in the genetic architecture of albinism
Vincent Michaud, Eulalie Lasseaux, … Panagiotis I. Sergouniotis·Nature CommunicationsPeer-reviewed·Jul 8, 2022
- A new rescue assay for genetic diagnosis of oculocutaneous albinism using MNT1 knock-out cells
Elina Mercier, Vincent Michaud, … Sophie Javerzat·medRxiv·Nov 26, 2025
- Dopachrome tautomerase variants in patients with oculocutaneous albinism.
Perrine Pennamen, Angèle Tingaud‐Sequeira, … Benoı̂t Arveiler·Genetics in MedicinePeer-reviewed·Oct 25, 2020
- The co-occurrence of genetic variants in the TYR and OCA2 genes confers susceptibility to albinism
David J. Green, Vincent Michaud, … Panagiotis I. Sergouniotis·medRxiv·Jan 19, 2023
- Systemic, RPE-directed AAV-Tyrosinase therapy restores ocular pigmentation in an OCA1 mouse model
Alessandra M. Larimer-Picciani, Lucas B Jacob, … Leah C. Byrne·bioRxiv·Jul 2, 2026
- Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of Hypopigmentation.
Monika B. Dolinska, Yuhong Wang, … Brian P. Brooks·bioRxiv·Oct 13, 2025